How many insider declarations has Anderman Todd filed?

Anderman Todd has filed 3 public insider declarations with SEC (Form 4).

What is Anderman Todd's role?

Anderman Todd's reported role is not specified by the regulator across the filings.

Which companies does Anderman Todd report trades for?

Anderman Todd reports trades for 2 companies, including Ocular Therapeutix, INC.

What is Anderman Todd's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 118k€.

← Executives ★ Sign in to follow

AT

Anderman Todd

OFFICER

·SEC (Form 4)

Ocular Therapeutix, INC OCULAR THERAPEUTIX, INC

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€118,096

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Anderman Todd. Director active across 2 companies, notably Ocular Therapeutix, INC. In total, 3 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €118k. History available since 7 October 2024. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Anderman Todd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Ocular Therapeutix, INC (US)OCULAR THERAPEUTIX, INC (US)

Declarations3 total

◆

Anderman Todd

Chief Legal OfficerExecutives2 Jan 2026Ocular Therapeutix, INC

0SEC ↗

64,900 shares0Common StockSEC:0001104659-26-001296:0

▼

Anderman Todd

Chief Legal OfficerExecutives8 Oct 2025OCULAR THERAPEUTIX, INC

$137,36934SEC ↗

11,132 shares@ US$12.34100.0% of flowCommon StockSEC:0001104659-25-098706:0

◆

Anderman Todd

Chief Legal OfficerExecutives7 Oct 2024Ocular Therapeutix, INC

0SEC ↗

98,700 shares0Common StockSEC:0001104659-24-107392:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

AT

Anderman Todd

OFFICER

·SEC (Form 4)

Ocular Therapeutix, INC OCULAR THERAPEUTIX, INC

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€118,096

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Discover the detailed record of transactions filed by Anderman Todd. Director active across 2 companies, notably Ocular Therapeutix, INC. In total, 3 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €118k. History available since 7 October 2024. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.